Coopervision Inc 5870 Stoneridge Drivesuite 1pleasanton Ca 94588 Pma Numberp180035 Supplement Numbers010 Date Received08 17 2022 Decision Date09 15 2022 Product Code Qit Advisory Committee Ophthalmic Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Coopervision Inc 5870 Stoneridge Drivesuite 1pleasanton Ca 94588 Pma Numberp180035 Supplement Numbers010 Date Received08 17 2022 Decision Date09 15 2022 Product Code Qit Advisory Committee Ophthalmic Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P180035S010 CooperVision, Inc.5870 Stoneridge Drivesuite 1pleasanton, CA 94588 PMA NumberP180035 Supplement NumberS010 Date Received08/17/2022 Decision Date09/15/2022 Product Code QIT  Advisory Committee Ophthalmic Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No	MiSight 1 day (omafilcon A)	2022-09-15